13F reference period
Q2 2026
Security Snapshot
VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX) Institutional Ownership
CUSIP: G9495L109
13F Institutional Holders and Ownership History from Q3 2022 to Q2 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Stock
- Symbol
- VRAX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 0
- Total 13F value
- $0
- Share change
- -21
- Value change
- -$4
- Number of holders
- 0
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock is tracked under CUSIP G9495L109.
- 0 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 1 to 0 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $4 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 0 institutions filings for Q2 2026.
Security key
G9495L109
13F reference period
Q2 2026
13F holders
0
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
VRAX full holder history
Virax Biolabs Group Ltd SEC filings
Virax Biolabs Group Ltd company facts
Virax Biolabs Group Ltd insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G9495L109:
As of 30 Jun 2026,
0
institutional investors reported holding
0
shares of
VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Headline period
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 0 | $0 | -$4 | 0 | |
| 2026 Q1 | 21 | $4 | $0.19 | 1 | |
| 2025 Q4 | 21 | $7 | $0.33 | 1 | |
| 2025 Q3 | 21 | $13 | +$13 | $0.62 | 1 |
| 2023 Q4 | 0 | $0 | -$10,891 | 0 | |
| 2023 Q3 | 33,509 | $10,891 | -$11,742 | $0.32 | 4 |
| 2023 Q2 | 57,338 | $22,763 | -$1,110,521 | $0.39 | 4 |
| 2023 Q1 | 1,643,242 | $1,140,856 | +$1,011,595 | $0.69 | 5 |
| 2022 Q4 | 184,903 | $132,616 | -$21,287 | $0.72 | 7 |
| 2022 Q3 | 58,373 | $183,000 | +$183,000 | $3.13 | 4 |